Form 8-K - Current report:
SEC Accession No. 0001493152-19-015853
Filing Date
2019-10-23
Accepted
2019-10-23 07:20:09
Documents
27
Period of Report
2019-10-23
Items
Item 7.01: Regulation FD Disclosure

Document Format Files

Seq Description Document Type Size
1 form8-k.htm 8-K 27267
2 ex99-1.htm EX-99.1 23492
3 ex99-1_001.jpg GRAPHIC 68112
4 ex99-1_002.jpg GRAPHIC 186252
5 ex99-1_003.jpg GRAPHIC 167728
6 ex99-1_004.jpg GRAPHIC 52197
7 ex99-1_005.jpg GRAPHIC 180315
8 ex99-1_006.jpg GRAPHIC 168370
9 ex99-1_007.jpg GRAPHIC 169791
10 ex99-1_008.jpg GRAPHIC 55904
11 ex99-1_009.jpg GRAPHIC 158192
12 ex99-1_010.jpg GRAPHIC 207223
13 ex99-1_011.jpg GRAPHIC 55950
14 ex99-1_012.jpg GRAPHIC 158215
15 ex99-1_013.jpg GRAPHIC 179293
16 ex99-1_014.jpg GRAPHIC 135576
17 ex99-1_015.jpg GRAPHIC 107979
18 ex99-1_016.jpg GRAPHIC 189454
19 ex99-1_017.jpg GRAPHIC 153950
20 ex99-1_018.jpg GRAPHIC 164678
21 ex99-1_019.jpg GRAPHIC 151782
22 ex99-1_020.jpg GRAPHIC 168589
23 ex99-1_021.jpg GRAPHIC 181387
24 ex99-1_022.jpg GRAPHIC 53761
25 ex99-1_023.jpg GRAPHIC 143372
26 ex99-1_024.jpg GRAPHIC 201612
27 ex99-1_025.jpg GRAPHIC 164405
  Complete submission text file 0001493152-19-015853.txt   5044959
Mailing Address 7380 COCA COLA DRIVE SUITE 106 HANOVER MD 21076
Business Address 7380 COCA COLA DRIVE SUITE 106 HANOVER MD 21076 443-776-3133
Processa Pharmaceuticals, Inc. (Filer) CIK: 0001533743 (see all company filings)

EIN.: 451539785 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 333-184948 | Film No.: 191162653
SIC: 2834 Pharmaceutical Preparations